← Browse by Condition
Medical Condition
biliary cancer
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 2
NCT06819215 Phase 1, Phase 2
Recruiting
Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors
Enrollment
188 pts
Location
China
Sponsor
Zhejiang Yangli Pharmaceutical...
NCT05849480 Phase 1, Phase 2
Recruiting
A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)
Enrollment
60 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT05517811
Recruiting
Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
Enrollment
400 pts
Location
United States
Sponsor
University of Colorado, Denver